Haleon PLC Logo

Haleon PLC

A global consumer healthcare company focused on improving everyday health.

HLN | IL

Overview

Corporate Details

ISIN(s):
GB00BMX86B70 (+2 more)
LEI:
549300PSB3WWEODCUP19
Country:
United Kingdom
Address:
BUILDING 5, FIRST FLOOR, THE HEIGHTS, KT13 0NY WEYBRIDGE

Description

Haleon PLC is a global consumer healthcare company focused on improving everyday health. The company develops and markets a portfolio of category-leading brands built on scientific innovation and trusted by consumers and healthcare professionals. Its product offerings span several key categories, including Oral Health, Pain Relief, Respiratory Health, and Vitamins, Minerals, and Supplements. Notable brands within its portfolio include Sensodyne, Advil, Voltaren, and Centrum. Haleon's mission is to deliver better everyday health with humanity, making it more achievable, inclusive, and sustainable.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 16:25
Director/PDMR Shareholding
English 37.9 KB
2025-12-01 11:40
Total Voting Rights and Capital
English 7.8 KB
2025-11-12 12:10
Director/PDMR Shareholding
English 38.0 KB
2025-11-10 08:25
Appointment of Vindi Banga as Chair
English 15.0 KB
2025-11-03 12:40
Total Voting Rights and Capital
English 7.8 KB
2025-10-30 08:10
Haleon 2025 Q3 Trading Statement
English 410.9 KB
2025-10-30 08:00
Haleon 2025 Q3 Trading Statement
English 14.7 KB
2025-10-10 13:45
Director/PDMR Shareholding
English 39.5 KB
2025-10-02 11:05
Director Declaration
English 6.9 KB
2025-10-02 08:00
Transaction in Own Shares & Buyback Update
English 19.2 KB
2025-10-01 11:00
Total Voting Rights and Capital
English 8.1 KB
2025-10-01 08:00
Transaction in Own Shares
English 18.0 KB
2025-09-29 08:00
Transaction in Own Shares
English 17.9 KB
2025-09-26 14:30
Director/PDMR Shareholding
English 115.8 KB
2025-09-24 16:00
Holding(s) in Company
English 39.0 KB

Automate Your Workflow. Get a real-time feed of all Haleon PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Haleon PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Haleon PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.